The Independent |
Who is to blame for pharmaceutical firm Mylan price gouging the EpiPen?
The Independent Since an outfit called Mylan acquired the “EpiPen” in 2007 the price of the emergency allergy treatment has risen almost five fold. Over that period Mylan’s boss, Heather Bresch, has apparently seen her pay shoot up almost sevenfold. In 2015 Turing … |
…

